Journal Title：Annals Of Clinical Biochemistry

Annals of Clinical Biochemistry is the fully peer reviewed international journal of the Association for Clinical Biochemistry and Laboratory Medicine.

Annals of Clinical Biochemistry accepts papers that contribute to knowledge in all fields of laboratory medicine, especially those pertaining to the understanding, diagnosis and treatment of human disease. It publishes papers on clinical biochemistry, clinical audit, metabolic medicine, immunology, genetics, biotechnology, haematology, microbiology, computing and management where they have both biochemical and clinical relevance. Papers describing evaluation or implementation of commercial reagent kits or the performance of new analysers require substantial original information. Unless of exceptional interest and novelty, studies dealing with the redox status in various diseases are not generally considered within the journal's scope. Studies documenting the association of single nucleotide polymorphisms (SNPs) with particular phenotypes will not normally be considered, given the greater strength of genome wide association studies (GWAS). Research undertaken in non-human animals will not be considered for publication in the Annals.

Annals of Clinical Biochemistry is also the official journal of NVKC (de Nederlandse Vereniging voor Klinische Chemie) and JSCC (Japan Society of Clinical Chemistry).

《臨床生物化學年鑒》是臨床生物化學和實驗室醫(yī)學協(xié)會的一份經(jīng)過同行評審的國際期刊。

《臨床生物化學年鑒》接受有助于實驗室醫(yī)學各個領(lǐng)域知識的論文，尤其是那些與人類疾病的理解、診斷和治療有關(guān)的論文。它發(fā)表與生化和臨床相關(guān)的臨床生物化學、臨床審計、代謝醫(yī)學、免疫學、遺傳學、生物技術(shù)、血液學、微生物學、計算和管理方面的論文。描述商業(yè)試劑盒的評估或?qū)嵤┗蛐路治鰞x性能的論文需要大量的原始信息。除非具有特別的興趣和新穎性，否則涉及各種疾病的氧化還原狀態(tài)的研究通常不被視為該期刊的收錄范圍。鑒于全基因組關(guān)聯(lián)研究 (GWAS) 的強度更大，記錄單核苷酸多態(tài)性 (SNP) 與特定表型關(guān)聯(lián)的研究通常不會被考慮。在非人類動物身上進行的研究將不會被考慮在《年鑒》上發(fā)表。

《臨床生物化學年鑒》也是 NVKC（荷蘭臨床化學協(xié)會）和 JSCC（日本臨床化學學會）的官方期刊。

Annals Of Clinical Biochemistry創(chuàng)刊于1960年，由SAGE Publications Ltd出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Clinical Biochemistry全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 ，影響因子指數(shù)2.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。